SLC2A1 and epilepsy: Genetic investigations including karyotype, PCR and fluorescence in situ hybridization for X‐fragile, CGH‐array, direct sequencing of MECP2, CDKL5, FOXG1, PCDH19, SLC2A1, and a multigene epilepsy panel, were all negative.